Efficacy and safety of biosimilar infliximab in bio-naïve patients with Crohn’s disease

Tsubasa Oike; Naoki Akizue; Yuki Ohta; Hirotaka Koseki; Masaya Saito; Yuya Yokoyama; Yushi Imai; Takashi Taida; Kenichiro Okimoto; Keiko Saito; Sadahisa Ogasawara; Tomoaki Matsumura; Tomoo Nakagawa; Makoto Arai; Tatsuro Katsuno; Yoshihiro Fukuda; Yoshio Kitsukawa; Jun Kato; Naoya Kato

doi:10.1016/j.ajg.2024.03.006

Citations

386

Views

Abstract not available for this publication.

Cite this Article (APA)

Tsubasa, O., Naoki, A., Yuki, O., Hirotaka, K., Masaya, S., Yuya, Y., Yushi, I., Takashi, T., Kenichiro, O., Keiko, S., Sadahisa, O., Tomoaki, M., Tomoo, N., Makoto, A., Tatsuro, K., Yoshihiro, F., Yoshio, K., Jun, K., Naoya, K. (2024). Efficacy and safety of biosimilar infliximab in bio-naïve patients with Crohn’s disease. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2024.03.006